|
GNPNAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.658040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.094800E-01 |
| Normal-vs-Stage2 |
2.943900E-02 |
| Normal-vs-Stage3 |
7.301900E-03 |
| Normal-vs-Stage4 |
9.109600E-02 |
| Stage1-vs-Stage2 |
8.435700E-03 |
| Stage1-vs-Stage3 |
2.103700E-03 |
| Stage1-vs-Stage4 |
6.254100E-02 |
| Stage2-vs-Stage3 |
6.834400E-01 |
| Stage2-vs-Stage4 |
4.955400E-01 |
| Stage3-vs-Stage4 |
6.618400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.124800E-01 |
| Normal-vs-AfricanAmerican |
7.613800E-02 |
| Normal-vs-Asian |
9.517000E-01 |
| Caucasian-vs-AfricanAmerican |
1.611180E-01 |
| Caucasian-vs-Asian |
5.626400E-01 |
| AfricanAmerican-vs-Asian |
9.546400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.024030E-01 |
| Normal-vs-Female |
2.842200E-01 |
| Male-vs-Female |
3.848800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.745600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.888200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.568000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.770200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.060450E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.82029999998379E-06 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.090000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.856000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.034600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.155400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.749000E-01 |
| Classical-VS-Follicular |
1.57959999524948E-08 |
| Classical-VS-Other |
8.513800E-02 |
| Classical-VS-Normal |
6.425000E-01 |
| Tall-VS-Follicular |
5.621400E-03 |
| Tall-VS-Other |
2.249600E-01 |
| Tall-VS-Normal |
7.773400E-01 |
| Follicular-VS-Other |
9.097200E-01 |
| Follicular-VS-Normal |
2.84709999998078E-06 |
| Other-VS-Normal |
2.304600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.317200E-03 |
| Normal-vs-N1 |
3.496200E-01 |
| N0-vs-N1 |
2.525800E-01 |
|
|
